Sci-Tech Times Uzbekistan
SEE OTHER BRANDS

Exploring the science and technology news of Uzbekistan

Sci-Tech Times Uzbekistan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Times Uzbekistan.

Press releases published on September 11, 2025

Sarat Ventures Y Innovations Biotech Fund investiert in Start-up-Unternehmen mit Schwerpunkt auf Saudi-Arabien und der MENA-Region
Le fonds Sarat Ventures Y Innovations Biotech Fund prévoit d’investir dans des entreprises en phase de démarrage, plus particulièrement en Arabie saoudite et dans la région MENA
Sarat Ventures Y Innovations Biotech Fund invertirá en empresas en etapa inicial con enfoque en Arabia Saudita y en la región MENA
קרן הביוטק Sarat Ventures Y Innovations תשקיע בחברות בשלבים מוקדמים עם דגש על ערב הסעודית ואזור המזרח התיכון וצפון אפריקה
サラット・ベンチャーズYイノベーションズ・バイオテック・ファンド (Sarat Ventures Y Innovations Biotech Fund)、サウジアラビアおよび中東・北アフリカ地域を中心とした初期段階の企業へ投資
Sarat Ventures Y Innovations Biotech Fund, 사우디아라비아 및 MENA 지역 중심의 초기 단계 기업에 투자
Sarat Ventures Y Innovations Biotech Fund Irá Investir em Empresas em Estágio Inicial com Foco na Arábia Saudita e na região MENA
Dayforce Named a Leader in the 2025 Gartner® Magic Quadrant™ for HCM Suites for 1,000+ Employee Enterprises for Sixth Consecutive Year
Aligned Data Centers Donates $100,000 to mikeroweWORKS Foundation, Championing Skilled Trades and Future Workforce Development
ASUS Listed on TIME’s World’s Best Companies 2025 for the Second Time
iPhone 17 Protection, Built for You, From Urban Armor Gear
Faraday Pharmaceuticals to Participate in Upcoming Investor Events
OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell Cancer
OSE Immunotherapeutics et la Fondation FoRT annoncent la fin du recrutement dans Combi-TED, l’étude clinique de Phase 2 évaluant Tedopi® en combinaison avec nivolumab ou docétaxel dans le cancer du poumon non à petites cellules
Lightcast and Carahsoft Partner to Bring Data-Driven Workforce Strategies to the Public Sector
RESTEM to Host R&D Day Highlighting its Next-Generation Immunomodulatory Treatment for Autoimmune and Inflammatory Diseases
Hume Health Body Pod Official Launch — Advanced Full Body Composition Analyzer
SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December 11, 2025
DOW SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Dow Inc. - DOW
SNAP SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Snap Inc. - SNAP

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions